查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853771

放射治療設備市場按技術、最終用戶和應用分類－2025-2032年全球預測

Radiation Therapy Equipment Market by Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，放射治療設備市場規模將達到 146.3 億美元，複合年成長率為 7.37%。

關鍵市場統計數據
基準年 2024 82.8億美元
預計年份：2025年 88.9億美元
預測年份 2032 146.3億美元
複合年成長率 (%) 7.37%

簡要介紹影響放射治療設備採購和實施的臨床、技術和營運力量的融合。

在影像技術、計畫演算法和治療平台進步的推動下，放射腫瘤學領域正經歷著技術革新和臨床整合的快速發展時期。治療機構優先考慮能夠提高治療精度、縮短治療時間並與多學科治療路徑整合的設備。隨著醫療服務模式轉向價值導向模式，臨床團隊需要的設備不僅要滿足嚴格的療效和安全性標準，還要能夠提高工作流程效率並改善病患體驗。在資金分配日益緊縮和監管審查不斷加強的背景下，策略採購決策越來越關注設備的生命週期可維護性、互通性和可證實的臨床效益。

同時，研究計畫和學術中心不斷突破治療模式的界限，探索劑量遞增策略、適應性治療方法和新型粒子的治療潛力。這種研究勢頭得益於患者群體和轉診醫生對治療效果和毒性緩解措施的日益了解，他們期望獲得清晰的證據。鑑於這些動態，管理人員和臨床領導者在評估升級或新設備的實施時，必須權衡技術能力、營運準備和報銷現實。臨床目標與設備選擇之間的明確一致性將決定醫療機構能否在保持財務永續性的同時最大限度地提高臨床療效。

自我調整成像、緊湊型交付平台、人工智慧驅動的規劃和服務彈性如何重塑臨床路徑和採購重點

多項變革性變化正在重塑放射治療生態系統，並改變治療的規劃、實施和評估方式。首先，影像引導和自適應放射治療工作流程的成熟，使得高度個人化的治療成為可能，能夠根據治療過程中解剖結構的變化進行調整，從而改變了對設備的要求以及對整合影像處理功能的需求。其次，緊湊型、成本最佳化的平台的出現，擴大了社區的治療覆蓋範圍，並刺激了基於設備價格、服務模式和總體擁有成本等方面的競爭。

第三，計算技術的進步，特別是自動化治療計劃和人工智慧輔助勾畫，正在改變醫療專業人員的技能組合，並凸顯了供應商提供軟體更新和檢驗框架的必要性。第四，以患者為中心的治療設計和低分割放射治療方案提高了對治療效率的預期，迫使醫療機構在速度和準確性之間尋求平衡。最後，隨著醫療機構優先考慮執行時間和可預測的維護成本，供應鏈韌性和售後服務策略變得日益重要。為了維持臨床相關性和營運效率，相關人員被迫重新評估臨床路徑、採購標準和供應商夥伴關係。

評估近期關稅政策對您營運的影響，並考慮如何減輕對供應鏈多元化和本地定序策略的干擾。

貿易政策調整帶來的新關稅措施，為醫療服務提供者和技術供應商帶來了一系列營運方面的考量。部分零件和整套放射治療系統的進口關稅會增加海外製造或依賴國際採購子系統的設備的購買成本。為此，採購團隊正在重新評估整體擁有成本，並強調模組化架構的重要性，這種架構允許逐步升級、本地維護和零件互換，從而降低跨境價格波動帶來的風險。

製造商和經銷商正在透過供應商網路多元化、盡可能實現最終組裝本地化以及重新談判服務合約來適應變化，從而為客戶維持可預測的生命週期經濟效益。因此，臨床規劃人員和資本委員會必須預見某些配置的前置作業時間將會延長，並優先考慮與現有基礎設施的兼容性，以避免代價高昂的維修。從正面來看，關稅可能會加速加強國內製造能力和售後市場生態系統的策略，從而為本地維護點和培訓專案創造機會。最終，這些貿易措施的累積影響將波及採購時間表、供應商選擇框架和長期維護計劃，需要臨床、財務和供應鏈相關人員的協調應對。

優先考慮投資和營運規劃，並利用關鍵的細分洞察，將技術模式、醫療服務環境和臨床應用連結起來。

了解技術、最終用戶和應用領域的細分，能夠為評估產品開發優先順序和推廣路徑提供結構化的視角。在考慮各種技術時，例如近距離放射治療（區分高劑量率和低劑量率方法）、直線加速器、質子治療和立體定位系統（區分高能量和低能量配置），每種技術都呈現不同的臨床權衡和資本投入。這些技術差異不僅影響臨床適應症，還影響屏蔽、影像整合和房間佔用等基礎設施需求，進而影響部署時間表和跨專業協作需求。

從最終用戶的觀點，門診手術中心（包括醫院附屬中心和獨立中心）的人員配備、報銷和容量模式與癌症研究中心不同。癌症研究中心又可進一步細分為政府和私人研究機構，以及私立和公立醫院，它們的採購管理和預算週期也各不相同。這些差異影響著採購考量、預期服務水準和培訓投入。針對不同疾病部位的應用細分，例如管治和神經系統治療（傳統放射療法和立體定位放射放射線手術發揮不同的作用）、乳癌（採用外照射和術中策略）、肺癌（採用外照射和立體定位放射治療）以及攝護腺癌（採用近距離放射治療和外治療方法），可以明確臨床工作流程的影響以及設備功能的優先順序。將技術映射到最終用戶和應用場景，可以揭示在哪些方面最需要整合、臨床證據生成和專業服務支持，從而推動技術應用並最佳化患者預後。

報銷、基礎設施投資和服務網路如何影響美洲、歐洲、中東和非洲以及亞太地區的設備採用和夥伴關係模式

區域動態影響全球範圍內的應用模式、監管路徑和夥伴關係模式。在美洲，報銷機制、先進癌症中心的集中以及醫院系統整合的趨勢，都在推動可擴展、高通量平台的需求，以支持複雜的適應症。該地區也高度重視服務網路和對設備故障的快速反應，這影響著供應商的選擇和售後市場策略。

在歐洲、中東和非洲，不同的監管環境和基礎設施投資水準導致了不同的技術採納曲線。高所得市場優先考慮尖端治療方法，而資源匱乏地區則更注重成本效益高、經久耐用的平台和強大的本地服務支援。跨境監管協調工作和區域卓越中心促進了知識轉移和合作臨床試驗。在亞太地區，腫瘤領域的強勁資本投入，以及私立醫院和研究中心數量的不斷成長，推動了對先進治療方法和可在分級診療環境中部署的緊湊型系統的需求。區域製造舉措和官民合作關係也進一步影響採購決策。這些區域模式凸顯了製定靈活的商業策略的必要性，這些策略需要適應報銷政策的實際情況、基礎設施的限制以及長期的培訓承諾。

競爭格局分析表明，供應商差異化和採購標準是由技術整合、服務模式和臨床夥伴關係決定的。

設備供應商之間的競爭日益取決於技術差異化、卓越服務以及臨床證據的協作創造。領先的供應商正在投資於互通性框架、雲端規劃解決方案和自適應交付能力，以提供超越硬體本身的綜合提案主張。與學術中心和臨床網路的夥伴關係有助於加速檢驗研究，並將技術優勢轉化為指南層級的臨床實踐。服務模式也隨之發展，包括基於結果的維護合約和效能保證，從而使供應商的獎勵與設施的運作和吞吐量目標保持一致。

規模較小的專業供應商專注於特定模式和改造解決方案，以延長現有設備的使用壽命；而規模較大的全球性公司則更重視規模、監管經驗和廣泛的服務網路。策略性收購和合作繼續被用來彌補能力缺口，尤其是在軟體、影像處理和粒子治療領域。對於採購者而言，供應商評估越來越重視生命週期支援、合格的培訓項目以及透明的軟體更新和合規藍圖。在這種競爭激烈的環境中，差異化體現在已證實的臨床療效、可預測的服務經濟性以及融入複雜的醫院IT和影像處理生態系統的能力。

為醫療保健領導者提供切實可行的建議，以使其採購、培訓和服務策略與臨床目標和營運韌性保持一致。

產業領導者應採取多管齊下的策略，使技術投資與臨床目標和財務限制保持一致。首先，優先選擇提供模組化升級路徑和開放互通性的平台，以保護資本投資並簡化與電子健康記錄和影像系統的整合。其次，投資於培訓計劃，提升物理學家、劑量師和治療師的技能，使其能夠充分利用自動化、自適應規劃和立體定位功能，從而最大限度地提高效率和患者安全。第三，協商服務契約，強調可衡量的正常運作承諾、可預測的備件供應以及本地技術人員認證，以降低生命週期內的不確定性。

此外，相關人員應與研究中心建立夥伴關係，共同製定方案並收集真實世界證據，以支持新適應症的發展和醫保報銷的討論。在進行大規模部署之前，應優先進行試點項目，以檢驗臨床和營運效益，並納入風險分擔條款，協調供應商和醫療服務提供者之間的獎勵。最後，應積極維護供應鏈緊急應變計畫，包括關鍵零件的多供應商採購，並考慮在當地組裝和維護，以最大限度地減少全球貿易中斷的影響。實施這些措施將使各機構能夠在改善臨床療效的同時，保障財務穩健和業務永續營運。

採用透明的混合方法研究途徑，結合臨床文獻綜述、相關人員訪談和設備性能分析，確保研究結果的可重複性。

本分析的研究方法結合了對同行評審的臨床文獻、監管文件、技術白皮書和設備性能報告的系統性回顧，以及對臨床醫生、醫學物理學家、採購人員和服務經理的訪談。研究將定性見解與設備規格、已發表的臨床試驗結果和已記錄的服務模式進行交叉比對，以全面了解設備的技術能力和運行限制。研究特別關注了近期關於自適應放射治療、立體定位技術和粒子治療結果的同儕審查證據，並將設備能力置於既定的臨床路徑中進行分析。

供應商文件和安裝案例研究有助於評估維護策略和售後支持，而當地監管指南和報銷政策簡報則有助於理解推廣障礙。保密訪談提供了關於採購週期、訓練負擔和停機容忍度的真實觀點。研究方法強調可重複性和資訊來源檢驗，必要時會與多個獨立資訊來源進行交叉核對，以減少偏差。這種混合方法的調查方法產生了可操作的見解，兼顧了臨床細微差別和實際操作考量。

簡潔的結論強調，需要平衡臨床創新、生命週期經濟和服務韌性，以實現癌症治療的永續改善。

總之，放射治療設備的採購和部署正處於曲折點，必須兼顧技術先進性、操作實用性和長期可維護性。影像導引、自適應計劃和緊湊型治療系統的進步為改善臨床療效和患者體驗提供了明確的機會。然而，要實現這些益處，需要採購委員會、臨床團隊和服務機構之間進行有意識的協調，以應對資金、培訓和監管方面的需求。

展望未來，採用模組化、可互通技術、投資於員工發展並達成穩健服務協議的機構，將更有能力應對不斷變化的貿易政策以及報銷和基礎設施方面的區域差異。與研究機構建立策略夥伴關係，並專注於產生真實世界證據，可以進一步增強臨床和商業性提案。採取嚴謹的技術應用方法——將臨床優先事項與生命週期經濟學和供應鏈韌性相結合——可以幫助醫療服務提供者在保持未來創新靈活性的同時，提供更高價值的醫療服務。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 引進人工智慧實現即時自適應放射治療協調
  • 整合磁振造影引導的線性加速系統，以增強治療過程中軟組織的視覺化效果
  • 全球對用於治療兒童和複雜癌症的質子治療中心的投資增加
  • 開發一種旨在縮短治療時間和減少對健康組織損傷的FLASH放射治療通訊協定。
  • 拓展立體定位放射治療方案，以更精準地針對寡轉移性癌症。
  • 推出一款緊湊型行動線性加速器，專為偏遠地區的照護現場放射治療而設計。
  • 擴大使用雲端基礎的治療計劃平台，並利用高級分析功能進行遠端協作。
  • 即時腫瘤追蹤技術的進步提高了精度並最大限度地減少了輻射暴露

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 放射治療設備市場：依技術分類

  • 近距離放射治療
    • 高劑量率
    • 低劑量率
  • 線性加速器
    • 高能量
    • 低能耗
  • 質子治療
  • 立體定位放射學系統

第9章：依最終用戶分類的放射治療設備市場

  • 門診手術中心
    • 醫院相關中心
    • 獨立中心
  • 癌症研究中心
    • 政府研究機構
    • 私人研究機構
  • 醫院
    • 私立醫院
    • 公立醫院

第10章 放射治療設備市場：依應用領域分類

  • 大腦和神經系統
    • 常規放療
    • 立體放射線手術
  • 胸部
    • 外樑
    • 手術過程中
  • 肺
    • 外樑
    • 立體定位軀幹 RT
  • 攝護腺
    • 近距離放射治療
    • 外樑

第11章 各地區的放射治療設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 放射治療設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：各國放射治療設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Siemens Healthineers AG
    • Elekta AB
    • Accuray Incorporated
    • ViewRay Incorporated
    • Ion Beam Applications SA
    • Mevion Medical Systems, Inc.
    • Brainlab AG
    • Sumitomo Heavy Industries, Ltd.
    • Hitachi, Ltd.
    • Best Theratronics Ltd.
Product Code: MRR-02026C4C95C5

The Radiation Therapy Equipment Market is projected to grow by USD 14.63 billion at a CAGR of 7.37% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 8.28 billion
Estimated Year [2025] USD 8.89 billion
Forecast Year [2032] USD 14.63 billion
CAGR (%) 7.37%

A concise introduction framing the converging clinical, technological, and operational forces reshaping radiation therapy equipment procurement and adoption

The radiation therapy landscape is undergoing a period of concentrated technical refinement and clinical integration, driven by advances in imaging, planning algorithms, and delivery platforms. Providers are prioritizing equipment that improves precision, reduces treatment times, and integrates with multidisciplinary care pathways. As care delivery shifts toward value-based models, clinical teams require devices that not only meet stringent efficacy and safety standards but also enable workflow efficiencies and patient experience improvements. Amidst tighter capital allocation and heightened regulatory scrutiny, strategic procurement decisions increasingly weigh lifecycle serviceability, interoperability, and demonstrable clinical benefit.

Concurrently, research programs and academic centers continue to push modality boundaries, exploring dose escalation strategies, adaptive treatment approaches, and the therapeutic potential of novel particles. This research momentum is complemented by a more informed patient population and referring physicians who expect clear evidence of outcomes and toxicity mitigation. Given these dynamics, executives and clinical leaders must synthesize technological capability with operational readiness and reimbursement realities when evaluating upgrades or new installations. Clear alignment between clinical goals and equipment selection will determine whether institutions maximize clinical outcomes while preserving financial sustainability.

How adaptive imaging, compact delivery platforms, AI-enabled planning, and service resilience are collectively reshaping clinical pathways and procurement priorities

Several transformative shifts are redefining the radiation therapy ecosystem and the way care is planned, delivered, and evaluated. First, the maturation of image-guided and adaptive radiotherapy workflows enables highly personalized treatments that adjust to anatomical changes across a course of care, thus altering equipment requirements and demand for integrated imaging capability. Second, the emergence of compact and cost-optimized platforms expands access to community settings while stimulating competition based on service models and total cost of ownership rather than capital price alone.

Third, computational advances-most notably in treatment planning automation and AI-assisted contouring-are changing workforce skill mixes and highlight the need for vendors to provide software updates and validation frameworks. Fourth, patient-centric design and reduced fractionation regimens are increasing throughput expectations, pushing institutions to balance speed with precision. Lastly, supply chain resilience and aftermarket service strategies have taken on heightened importance as providers prioritize uptime and predictable maintenance costs. Together, these shifts compel stakeholders to re-evaluate clinical pathways, procurement criteria, and vendor partnerships to remain clinically relevant and operationally efficient.

Assessing the operational consequences of recent tariff policies and how supply diversification and local servicing strategies can mitigate procurement disruption

The introduction of new tariff measures originating from trade policy adjustments has introduced a cascade of operational considerations for healthcare providers and technology suppliers. Import duties on select components and finished radiotherapy systems have the potential to raise acquisition costs for equipment that is manufactured abroad or reliant on internationally sourced subsystems. In response, procurement teams are reassessing total cost of ownership calculations and placing greater emphasis on modular architectures that permit phased upgrades, local serviceability, and parts interchangeability to mitigate exposure to cross-border price volatility.

Manufacturers and distributors are adapting by diversifying supplier networks, localizing final assembly where feasible, and renegotiating service contracts to preserve predictable lifecycle economics for customers. Clinical planners and capital committees must therefore anticipate longer lead times for certain configurations and prioritize compatibility with existing infrastructure to avoid costly retrofits. On the positive side, tariffs can accelerate strategies that strengthen domestic manufacturing capabilities and aftermarket ecosystems, creating opportunities for localized maintenance hubs and training programs. Ultimately, the cumulative impact of these trade measures will be felt across procurement timelines, vendor selection frameworks, and long-term maintenance planning, requiring coordinated responses from clinical, financial, and supply chain stakeholders.

Key segmentation insights linking technology modalities, healthcare delivery settings, and clinical applications to prioritize investments and operational planning

Understanding segmentation across technology, end user, and application provides a structured lens to evaluate product development priorities and adoption pathways. When technologies are considered, modalities such as brachytherapy-distinguishing high dose rate and low dose rate approaches-alongside linear accelerators differentiated by high energy and low energy configurations, proton therapy, and stereotactic systems each present distinct clinical trade-offs and capital profiles. These technology distinctions influence not only clinical indication suitability but also infrastructure requirements such as shielding, imaging integration, and room footprint, which in turn affect deployment timelines and multidisciplinary coordination requirements.

From an end user perspective, ambulatory surgical centers-comprising both hospital-affiliated centers and standalone centers-operate under different staffing, reimbursement, and throughput models compared with cancer research centers, which are further categorized into government research institutes and private research institutes, and hospitals, where private hospitals and public hospitals have divergent procurement governance and budget cycles. These differences shape purchase considerations, service level expectations, and training investments. Application segmentation across disease sites such as brain and nervous system treatments, where conventional radiotherapy and stereotactic radiosurgery play distinct roles, breast cancer managed via external beam and intraoperative strategies, lung cancer treated with external beam and stereotactic body radiotherapy, and prostate cancer approached through brachytherapy and external beam modalities, clarifies clinical workflow impacts and device feature priorities. Mapping technologies to end users and applications reveals where integration, clinical evidence generation, and specialized service support are most needed to drive adoption and optimize patient outcomes.

How regional reimbursement, infrastructure investment, and service networks across the Americas, Europe Middle East & Africa, and Asia-Pacific shape equipment adoption and partnership models

Regional dynamics influence adoption patterns, regulatory pathways, and partnership models across the globe. In the Americas, reimbursement frameworks, high concentration of advanced cancer centers, and a trend toward consolidations among hospital systems drive demand for scalable, high-throughput platforms that support complex indications. This region also places a premium on service networks and rapid response for equipment downtime, which shapes vendor selection and aftermarket strategies.

Across Europe, the Middle East & Africa, diverse regulatory landscapes and variable infrastructure investment levels result in a heterogeneous adoption curve where high-income markets prioritize cutting-edge modalities and lower-resource settings focus on cost-effective, durable platforms with strong local service support. Cross-border regulatory harmonization efforts and regional centers of excellence facilitate knowledge transfer and collaborative clinical trials. In the Asia-Pacific region, robust capital investment in cancer care combined with a growing number of privately funded hospitals and research centers propels demand for both advanced modalities and compact systems that can be deployed in tiered healthcare settings. Local manufacturing initiatives and public-private partnerships further influence procurement decisions. These regional patterns underscore the need for flexible commercial strategies that adapt to reimbursement realities, infrastructure constraints, and long-term training commitments.

Competitive landscape analysis showing how technology integration, service models, and clinical partnerships define vendor differentiation and procurement criteria

Competitive dynamics among equipment providers are increasingly defined by a combination of technological differentiation, service excellence, and collaborative clinical evidence generation. Leading vendors invest in interoperability frameworks, cloud-enabled planning solutions, and adaptive delivery capabilities to offer an integrated value proposition that extends beyond the hardware. Partnerships with academic centers and clinical networks accelerate validation studies and help translate technological advantages into guideline-level clinical practice. Service models have evolved to include outcome-based maintenance contracts and performance guarantees that align vendor incentives with institutional uptime and throughput targets.

Smaller and niche suppliers focus on specialized modalities or retrofit solutions that extend the life of installed bases, while larger global corporations emphasize scale, regulatory experience, and expansive service footprints. Strategic acquisitions and alliances continue to be a lever for filling capability gaps, particularly in software, imaging, and particle therapy domains. For purchasers, vendor evaluation now prioritizes lifecycle support, credentialed training programs, and transparent roadmaps for software updates and regulatory compliance. These competitive behaviors create an environment where differentiation is measured by demonstrable clinical impact, predictable service economics, and the ability to integrate into complex hospital IT and imaging ecosystems.

Actionable recommendations for healthcare leaders to align procurement, training, and service strategies with clinical goals and operational resilience

Industry leaders should adopt a multi-pronged strategy to align technological investments with clinical objectives and fiscal constraints. First, prioritize platforms that offer modular upgrade paths and open interoperability to protect capital investments and simplify integration with electronic health records and diagnostic imaging systems. Second, invest in training initiatives that upskill physicists, dosimetrists, and therapists to fully leverage automation, adaptive planning, and stereotactic delivery capabilities, thereby maximizing throughput and patient safety. Third, negotiate service agreements that emphasize measurable uptime commitments, predictable spare parts availability, and local technician certification to reduce lifecycle uncertainty.

Additionally, stakeholders should pursue partnerships with research centers to co-develop protocols and real-world evidence that support new indications and reimbursement discussions. Emphasize pilot programs that validate clinical and operational benefits in situ before large-scale rollouts, and incorporate risk-sharing clauses to align vendor and provider incentives. Finally, maintain active supply chain contingency planning that includes multi-sourcing of critical components and consideration of local assembly or maintenance hubs to minimize exposure to global trade disruptions. By implementing these measures, organizations can enhance clinical outcomes while protecting financial resilience and operational continuity.

A transparent mixed-methods research approach combining clinical literature review, stakeholder interviews, and device performance analysis to ensure reproducible insights

The research underpinning this analysis combined a systematic review of peer-reviewed clinical literature, regulatory filings, technical white papers, and device performance reports with targeted interviews of clinicians, medical physicists, procurement leads, and service managers. Qualitative insights were triangulated with equipment specifications, published clinical trial outcomes, and documented service models to ensure a comprehensive understanding of both technological capabilities and operational constraints. Particular attention was paid to recent peer-reviewed evidence on adaptive radiotherapy, stereotactic techniques, and particle therapy outcomes to contextualize device capabilities within established clinical pathways.

Vendor documentation and installation case studies informed assessments of maintenance strategies and aftermarket support, while regional regulatory guidance and reimbursement policy briefings shaped the interpretation of adoption barriers. Confidential interviews provided real-world perspectives on procurement cycles, training burdens, and downtime tolerance. The methodology emphasized reproducibility and source validation, and where appropriate, findings were cross-checked against multiple independent sources to reduce bias. This mixed-methods approach yields actionable insights that balance clinical nuance with pragmatic operational considerations.

A concise conclusion emphasizing the need to balance clinical innovation, lifecycle economics, and service resilience to achieve sustainable improvements in cancer care

In conclusion, radiation therapy equipment procurement and deployment are at an inflection point where technological sophistication must be balanced with operational pragmatism and long-term serviceability. Advancements in image guidance, adaptive planning, and compact delivery systems present clear opportunities to improve clinical outcomes and patient experience. However, realizing these benefits requires deliberate alignment across procurement committees, clinical teams, and service organizations to manage capital, training, and regulatory demands.

Looking ahead, organizations that adopt modular, interoperable technologies, invest in workforce development, and negotiate robust service arrangements will be better positioned to navigate trade policy shifts and regional variances in reimbursement and infrastructure. Strategic partnerships with research institutions and a focus on generating real-world evidence will further strengthen clinical and commercial propositions. By taking a disciplined approach to technology adoption-one that integrates clinical priorities with lifecycle economics and supply chain resilience-providers can deliver higher-value care while preserving flexibility for future innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of artificial intelligence for real time adaptive radiation therapy treatment adjustments
  • 5.2. Integration of MRI guided linear accelerator systems for enhanced soft tissue visualization during treatment
  • 5.3. Rising investments in proton beam therapy centers for pediatric and complex cancer cases worldwide
  • 5.4. Development of FLASH radiotherapy protocols aimed at reducing treatment time and healthy tissue damage
  • 5.5. Expansion of stereotactic body radiotherapy solutions targeting oligometastatic cancers with higher precision
  • 5.6. Emergence of compact mobile linear accelerators designed for point of care radiotherapy in remote locations
  • 5.7. Growing use of cloud based treatment planning platforms with advanced analytics for remote collaboration
  • 5.8. Advancements in real time tumor tracking technologies to improve accuracy and minimize radiation exposure

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radiation Therapy Equipment Market, by Technology

  • 8.1. Brachytherapy
    • 8.1.1. High Dose Rate
    • 8.1.2. Low Dose Rate
  • 8.2. Linear Accelerators
    • 8.2.1. High Energy
    • 8.2.2. Low Energy
  • 8.3. Proton Therapy
  • 8.4. Stereotactic Systems

9. Radiation Therapy Equipment Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Hospital-Affiliated Centers
    • 9.1.2. Standalone Centers
  • 9.2. Cancer Research Centers
    • 9.2.1. Government Research Institutes
    • 9.2.2. Private Research Institutes
  • 9.3. Hospitals
    • 9.3.1. Private Hospitals
    • 9.3.2. Public Hospitals

10. Radiation Therapy Equipment Market, by Application

  • 10.1. Brain And Nervous System
    • 10.1.1. Conventional RT
    • 10.1.2. Stereotactic Radiosurgery
  • 10.2. Breast
    • 10.2.1. External Beam
    • 10.2.2. Intraoperative
  • 10.3. Lung
    • 10.3.1. External Beam
    • 10.3.2. Stereotactic Body RT
  • 10.4. Prostate
    • 10.4.1. Brachytherapy
    • 10.4.2. External Beam

11. Radiation Therapy Equipment Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Radiation Therapy Equipment Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Radiation Therapy Equipment Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Siemens Healthineers AG
    • 14.3.2. Elekta AB
    • 14.3.3. Accuray Incorporated
    • 14.3.4. ViewRay Incorporated
    • 14.3.5. Ion Beam Applications S.A.
    • 14.3.6. Mevion Medical Systems, Inc.
    • 14.3.7. Brainlab AG
    • 14.3.8. Sumitomo Heavy Industries, Ltd.
    • 14.3.9. Hitachi, Ltd.
    • 14.3.10. Best Theratronics Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. RADIATION THERAPY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. RADIATION THERAPY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. RADIATION THERAPY EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY